COMPARATIVE EPIDEMIOLOGY OF ATOPIC DERMATITIS IN KYRGYZSTAN AND OTHER COUNTRIES (LITERATURE REVIEW)
DOI:
https://doi.org/10.54890/1694-8882-2025-3-53Abstract
Atopic dermatitis is a chronic inflammatory skin disease characterized by itching, dryness, flaking, and recurrence. It is one of the most common allergic dermatoses and has a significant impact on the quality of life of patients, especially children and adolescents. According to the World Health Organization, the prevalence of atopic dermatitis among children ranges from 10 to 20%, and among adults, from 1 to 3%. In the Kyrgyz Republic, the incidence of the disease is increasing, especially in large cities and industrially developed regions. The highest number of visits is recorded in the spring and fall, due to seasonal climate changes and increased allergen load. The increase in atopic dermatitis cases in Kyrgyzstan is linked to environmental changes, urbanization, and lifestyle changes. Lack of awareness among parents and teachers about proper skin care for children leads to frequent flare-ups and complications. The increasing incidence of atopic dermatitis is the result of a combination of heredity and environmental factors. The main causes are urbanization, pollution, loss of biodiversity, and lifestyle changes. To slow this trend, environmental measures, education, and prevention from childhood are necessary. This requires the active implementation of prevention programs at the clinic and school level, advanced training for healthcare workers, and public outreach. Atopic dermatitis is a global problem, the incidence of which is increasing worldwide, especially among children, and is often chronic. The prevalence and characteristics of atopic dermatitis in Kyrgyzstan have not been adequately studied; however, as elsewhere, it is a serious condition that reduces quality of life. Atopic dermatitis is a significant medical and social problem that requires a comprehensive approach to diagnosis, treatment, and prevention. The development and implementation of national programs for the control of atopic dermatitis in the Kyrgyz Republic can help reduce the prevalence of the disease and improve the quality of life of patients.
Keywords:
dermatitis, prevalence, incidence, review, preventionReferences
1. Tian J, Zhang D, Yang Y, Huang Y, Wang L, Yao X, et al. Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study. Br J Dermatol. 2023;190(1):55-61. https://doi.org/10.1093/bjd/ljad339
2. Migliavaca CB, Lazzarini R, Stein C, Escher GN, de Gaspari CN, Dos Santos HWG, et al. Prevalence of Atopic Dermatitis: A Systematic Review and Meta-Analysis. Dermatitis. Published online August 12, 2024. https://doi.org/10.1089/derm. 2024.0165
3. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):120422. https://doi.org/10.1016/S0140-6736(20)30925-9
4. Yakupu A, Aimaier R, Yuan B, Chen B, Cheng J, Zhao Y, et al. The burden of skin and subcutaneous diseases: findings from the Global Burden of Disease Study 2019. Front Public Health. 2023;11:1145513. https://doi.org/10.3389/fpubh.2023. 1145513
5. von Stülpnagel CC, Augustin M, Dupmann L, da Silva N, Sommer R. Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases – a systematic review. J Eur Acad Dermatol Venereol. 2021;35(11):2166–84. https://doi.org/10.1111/jdv.17348
6. Сулайманова Н.Д., Тухватшин Р.Р., Койбагарова А.А., Усубалиев М.Б., Шакирова А.Т. Сравнительная оценка заболеваемости атопическим дерматитом среди больных г. Бишкек и Нарынской области. Тенденции развития науки и образования. 2023;(100-4):47–51. https://doi.org/10.18411/trnio-08-2023-168
7. AAAAI/ACAAI JTF Atopic Dermatitis Guideline Panel; Chu DK, et al. Atopic dermatitis (eczema) guidelines: 2023 AAAAI /ACAAI Joint Task Force GRADE- and IOM-based recommendations. Ann Allergy Asthma Immunol. 2024;132(3):274-312. https://doi.org/10.1016/j.anai.2023.11.009
8. Chu DK, Chu AWL, Rayner DG, Guyatt GH, Yepes-Nuñez JJ, Gomez-Escobar L, et al. Topical treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials. J Allergy Clin Immunol. 2023;152 (6):1493-1519. https://doi.org/10.1016/j.jaci.2023.08.030
9. Werfel T, Heratizadeh A, Aberer W, et al. S3 Guideline Atopic dermatitis: Part 1 - General aspects, topical and non-drug therapies, special patient groups. J Dtsch Dermatol Ges. 2024;22(1):137-153. https://doi.org/10.1111/ddg.15230
10. Davis DMR, Drucker AM, Alikhan A, et al. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies. J Am Acad Dermatol. 2024;90(2):e43-e56. https://doi.org/10.1016/j.jaad.2023.08.102
11. Davis DMR, Frazer-Green L, Alikhan A, et al. Focused update: Guidelines of care for the management of atopic dermatitis in adults. J Am Acad Dermatol. 2025;93(3):745.e1-745.e7. https://doi.org/10.1016/j.jaad.2025.05.1386
12. Werfel T, Heratizadeh A, Aberer W, et al. S3 Guideline Atopic dermatitis: Part 1 - General aspects, topical and nondrug therapies, special patient groups. J Dtsch Dermatol Ges. 2024;22(1):137-153. https://doi.org/10.1111/ddg.15230
13. Beck LA, Bissonnette R, Deleuran M, et al. Dupilumab in Adults with Moderate to Severe Atopic Dermatitis: A 5-Year Open-Label Extension Study. JAMA Dermatol. 2024;160(8):805-812. https://doi.org/10.1001/jamadermatol.2024.1536
14. Paller AS, Pinter A, Wine Lee L, et al. Correctionto: Efficacy and Safety of Dupilumab Treatmentwith Concomitant Topical Corticosteroids inChildren Aged 6 Months to 5 Years with SevereAtopic Dermatitis. Adv Ther. 2024;41(6):2536- 2539. https://doi.org/10.1007/s12325-024-02866-1
15. Узаков О.Ж. Атопический дерматит: новыеаспекты этиопатогенеза, клиники,диагностики, терапии и профилактики. Ош;2012. 52 с.
16. Li Z, Gu J, Tang T, Huang X, Wu Y, Li Y, et al.The Global Burden of Atopic Dermatitis inElderly Populations: Trends, Disparities, andFuture Projections. Healthcare (Basel).2025;13(7):788. https://doi.org/10.3390/healthcare13070788
17. Zablotsky B, Black LI, Akinbami LJ. Diagnosed Allergic Conditions in Children Aged 0-17 Years:United States, 2021. NCHS Data Brief.2023;459:1-8.
18. Сулайманов Ш.А., Муратова Ж.К.Атопический дерматит у детей, жителей юга Кыргызстана. Вестник КазНМУ. 2019;2:281-284.
19. Муратова Ж.К. Изучение распространенностисимптомов атопического дерматита у детей школьного возраста в г. Жалал-Абад. Медицина Кыргыстана. 2015;4:47-50.
20. Сулайманов Ш.А., Муратова Ж.К. Новое в изучении эпидемиологии атопического дерматита у детей. Медицина Кыргыстана.2015;4:61-62.
21. Балаболкин, И.И. Актуальные проблемы аллергологии детского возраста насовременном этапе. Педиатрия. 2012;91(3):15-17.
22. Хоха Р.Н Динамика распространенности симптомов атопического дерматита у детей (по результатам III фазы, ISAAC) в отдельном административно-территориальном регионе Республики Беларусь (Гродненская область). Журнал Гродненского государственного медицинского университета. 2016;1:45-50.
23. Астафьева Н.Г., Еремина М.Г., Еремин А.В.Индивидуальное бремя атопического дерматита. Саратовский научно-медицинский журнал. 2013;9(3):543-548.
24. Шаманов И.Г., Бешимова А.Б.Распространенность симптомов атопического дерматита и их взаимосвязь с респираторной аллергией у детей младшего школьного возраста. Казанский медицинский журнал. 2013;94(1):55–59.
Downloads
Published
How to Cite
Issue
Section
